1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma
- Contribution to journal › Article
- 2022
-
Mark
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
- Contribution to journal › Article
-
Mark
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
- Contribution to journal › Article
- 2021
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
- Contribution to journal › Article
- 2019
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
- Contribution to journal › Article
-
Mark
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
- Contribution to journal › Article
- 2018
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
- Contribution to journal › Article
